Business ❯Healthcare ❯Pharmaceuticals

Vaccine Development

Moderna Gardasil Norovirus Vaccine Public Health Policy

Merck's Q3 Earnings Exceed Expectations Despite Gardasil Sales Slump in China

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline